作者
Kenneth E Bernstein, Frank S Ong, Wendell-Lamar B Blackwell, Kandarp H Shah, Jorge F Giani, Romer A Gonzalez-Villalobos, Xiao Z Shen, Sebastien Fuchs
发表日期
2013/1/1
来源
Pharmacological reviews
卷号
65
期号
1
页码范围
1-46
出版商
American Society for Pharmacology and Experimental Therapeutics
简介
Angiotensin-converting enzyme (ACE) is a zinc-dependent peptidase responsible for converting angiotensin I into the vasoconstrictor angiotensin II. However, ACE is a relatively nonspecific peptidase that is capable of cleaving a wide range of substrates. Because of this, ACE and its peptide substrates and products affect many physiologic processes, including blood pressure control, hematopoiesis, reproduction, renal development, renal function, and the immune response. The defining feature of ACE is that it is composed of two homologous and independently catalytic domains, the result of an ancient gene duplication, and ACE-like genes are widely distributed in nature. The two ACE catalytic domains contribute to the wide substrate diversity of ACE and, by extension, the physiologic impact of the enzyme. Several studies suggest that the two catalytic domains have different biologic functions. Recently, the X-ray …
引用总数
20132014201520162017201820192020202120222023202462425382834373035412619